MEREDITH MOLNAR: Open Payments
NPI 1265961973 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 39 payments from 12 companies in 2025. Trend: 2023 $1,131 · 2024 $1,047 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $187 |
| AstraZeneca Pharmaceuticals LP | 8 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $132 |
| Novo Nordisk Inc | 3 | $59 |
| Insulet Corporation | 2 | $58 |
| Astellas Pharma US Inc | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
Products named: Kerendia, MOUNJARO, JARDIANCE, FARXIGA, Omnipod, Ozempic, Veozah, BREZTRI.
Industry payments across FL — which companies pay providers there.
